anti-atherosclerotic effect of olive leaf extract is related to suppressed inflammatory response in rabbits with experimental atherosclerosis

• Published in: European journal of nutrition 2008-08, Vol.47 (5), p.235-243
• Main Authors: Wang, Lihui, Geng, Chengyan, Jiang, Liping, Gong, Dezheng, Liu, Dayu, Yoshimura, Hiroyuki, Zhong, Laifu
• Format: Article
• Language: English
• Subjects: Animals; Atherosclerosis - blood; Atherosclerosis - drug therapy; Atherosclerosis - metabolism; Biological and medical sciences; Chemistry; Chemistry and Materials Science; Cholesterol - blood; Cholesterol, HDL - blood; Cholesterol, LDL - blood; Diet; Feeding. Feeding behavior; Fundamental and applied biological sciences. Psychology; Hypercholesterolemia - complications; Hypercholesterolemia - metabolism; Inflammation - blood; Inflammation - drug therapy; Inflammation - metabolism; Male; Malondialdehyde - blood; NF-kappa B - genetics; NF-kappa B - metabolism; Nutrition; Olea - chemistry; Original Contribution; Plant Extracts - pharmacology; Plant Leaves - chemistry; Rabbits; Random Allocation; Triglycerides - blood; Tumor Necrosis Factor-alpha - genetics; Tumor Necrosis Factor-alpha - metabolism; Vascular Cell Adhesion Molecule-1 - genetics; Vascular Cell Adhesion Molecule-1 - metabolism; Vertebrates: anatomy and physiology, studies on body, several organs or systems
• ISSN: 1436-6207; 1436-6215
• DOI: 10.1007/s00394-008-0717-8

Background The anti-atherogenic effect of olive leaf extract is supposed to be related to its activities of anti-oxidation and anti-inflammation. Aim of the study To prove the effect of anti-atherosclerosis by olive leaf extract (OLE) and to elucidate the mechanism behind. Methods Twenty-four rabbits were assigned to the control, high lipid diet (HLD) and OLE group that were fed with standard diet, HLD and HLD supplemented with OLE, respectively. Serum levels of atherosclerosis related markers, triglyceride (TG), total cholesterol (T-CHO), low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C) and malondialdehyde (MDA) were detected at the ends of week 2, 4 and 6. Surface lesions and thickness of intimas were measured at the end of week6. The protein and/or mRNA expressions of inflammation factors, monocyte chemoattractant protein (MCP)-1, vascular cell adhesion molecule (VCAM)-1, nuclear factor-kappa B (NF-κB) and tumor necrosis factor α (TNF-α) were investigated by immunohistochemistry and RT-PCR. Results Atherosclerotic lesions were found in the HLD and OLE groups but not in the control group. In comparison with that in the HLD group, reduced size and thickness of intima (0.31 ± 0.26 in the HLD group versus 0.10 ± 0.03 mm in the OLE group) were found in the OLE group. The MDA level, an indicator of antioxidant status, was 35.27 ± 15.37 in the HLD group and 20.63 ± 11.52 nmol/ml in the OLE group. The level of CHO, TG and LDL-C were 104.46 ± 30.34, 2.48 ± 1.11, 82.83 ± 28.44 mmol/l in the HLD group versus 83.03 ± 27.23, 1.84 ± 0.44, 59.51 ± 23.72 mmol/l in the OLE group. Down-regulated expressions of MCP-1, VCAM-1, NF-κB and TNF-α at both protein and mRNA level (P < 0.05) were also found with the administration of OLE. Conclusion This study proved the effect of OLE on inhibition of atherosclerosis, which is related to the suppressed inflammatory response.